Skip to main content
. 2021 Apr 6;49(4):03000605211004201. doi: 10.1177/03000605211004201

Table 3.

Clinical factors according to time to diagnosis.

Variables
Time to diagnosis, n (%)
p-value
Within 1 year (n = 504) 1–5 years (n = 265) Over 5 years (n = 168) Total (n = 937)
Sex (male) n (%) 386 (77.7) 201 (76.4) 19 (77.2) 716 (77.2) 0.829
Age >40 years 246 (49.6) 156 (60.2) 130 (77.8) 532 (57.7) <0.001**
Disease duration (months)#,a 72 (29–132) 95.5 (41–180) 96 (30–180) 76 (36–144) <0.005**
 ≤5 years 225 (48.2) 95 (39.3) 63 (39.9) 383 (44.2) 0.024*
 >5 years 242 (51.8) 147 (60.7) 95 (60.1) 484 (55.8)
Pain site (multiple responses allowed)
 Neck 103 (20.4) 62 (23.4) 45 (26.8) 210 (22.4) 0.077
 Back 73 (14.5) 47 (17.7) 38 (22.6) 158 (16.9) 0.014*
 Lower back 173 (34.3) 95 (35.8) 51 (30.4) 319 (34.0) 0.494
 Buttock/coccyx 126 (25.0) 93 (35.1) 48 (28.6) 267 (28.5) 0.094
 Hip 87 (17.3) 52 (19.6) 38 (22.6) 177 (18.9) 0.116
 Heel 35 (6.9) 19 (7.2) 7 (4.2) 61 (6.5) 0.291
 Other 88 (17.5) 31 (11.7) 17 (10.1) 136 (14.5) 0.007**
First diagnosis (multiple responses allowed)
 AS 232 (45.8) 67 (25.3) 45 (26.8) 344 (36.7) <0.001**
 Herniated disc 59 (11.7) 50 (18.9) 40 (23.8) 149 (15.9) <0.001**
 Not specific 59 (11.7) 43 (16.2) 22 (13.1) 124 (13.2) 0.348
 Hip arthropathy 53 (10.5) 31 (11.7) 23 (13.7) 107 (11.4) 0.263
 Chronic myalgia 22 (4.4) 22 (8.3) 8 (4.8) 52 (5.5) 0.388
 Low back pain owing to poor posture 18 (3.6) 24 (9.1) 18 (10.7) 60 (6.4) <0.001**
 Rheumatoid arthritis 8 (1.6) 11 (4.2) 3 (1.8) 22 (2.3) 0.417
 Gout 6 (1.2) 3 (1.1) 0 (0.0) 9 (1.0) 0.226
 Plantar fasciitis 5 (1.0) 3 (1.1) 0 (0.0) 8 (0.9) 0.324
 Uveitis 2 (0.4) 0 (0.0) 3 (1.8) 5 (0.5) 0.103
 Other 46 (9.1) 23 (8.7) 13 (7.7) 80 (8.5) 0.588
Symptoms and extra-articular manifestations (multiple responses allowed)
 Fatigue 290 (57.5) 168 (63.4) 106 (63.1) 564 (60.2) 0.113
 Myalgia 182 (36.1) 120 (45.3) 69 (41.1) 371 (39.6) 0.081
 Arthralgia 179 (35.5) 115 (43.4) 56 (33.3) 350 (37.4) 0.825
 Depressed mood 111 (22.0) 74 (27.9) 58 (34.5) 243 (25.9) 0.001**
 Weight loss 39 (7.7) 21 (7.9) 10 (6.0) 70 (7.5) 0.528
 Uveitis 106 (21.0) 69 (26.0) 65 (38.7) 240 (25.6) <0.001**
 Skin rash 51 (10.1) 34 (12.8) 24 (14.3) 109 (11.6) 0.109
 Oral ulcer 29 (5.8) 21 (7.9) 14 (8.3) 64 (6.8) 0.180
 Diarrhea, abdominal pain 42 (8.3) 23 (8.7) 18 (10.7) 83 (8.9) 0.388
 Anterior chest pain 88 (17.5) 57 (21.5) 37 (22.0) 182 (19.4) 0.125
 Pain in Achilles tendon 83 (16.5) 38 (14.3) 27 (16.1) 148 (15.8) 0.733
 Dyspnea 14 (2.8) 17 (6.4) 7 (4.2) 38 (4.1) 0.153
 Comorbid diseases 218 (43.3) 135 (50.9) 101 (60.1) 454 (48.5) <0.001**

#Kruskal–Wallis test or chi-square test was used to compare the three groups. Values are median (interquartile range) unless otherwise indicated. Comorbid diseases include those listed in Table 1.

*p<0.05, **p<0.005.

aSignificant difference between groups within 1 year and 1 to 5 years with Mann–Whitney U test.

AS, ankylosing spondylitis.